Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Machtay

MA05.09 PFS and Cardiac-Toxicity-Adjusted-PFS as Predictors of OS in Locally Advanced NSCLC Treated With Concurrent Chemoradiation

Journal of Thoracic Oncology

English

The Clinical Value of FDG-PET/MRI in Treatment Planning and as a Predictor of Disease Response in High–Dose Rate Interstitial Brachytherapy for Locally Advanced Gynecologic Malignancies

International Journal of Radiation Oncology Biology Physics

English

Related publications

PC05.01 Debate 1: Which Is Most Important Efficacy Endpoint in First Line Trials in Advanced NSCLC PFS or OS - Point of View: PFS

Journal of Thoracic Oncology

English

Quality of Survivorship Among Patients With Locally Advanced NSCLC Treated With Chemoradiation on RTOG 0617

International Journal of Radiation Oncology Biology Physics

English

OA07.07 PFS and OS Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

Journal of Thoracic Oncology

English

(P080) Immune Parameters as Predictors of Pneumonitis and Survival in Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation

International Journal of Radiation Oncology Biology Physics

English

P2.17-25 Post-Treatment Neutrophil to Lymphocyte Ratio in Locally Advanced NSCLC Patients Treated With Concurrent Chemoradiotherapy

Journal of Thoracic Oncology

English

P3.01-084 Analysis on ALTER0303 Trial: ACECs Level May Correlate With Metastases Burden and Predict PFS of Anlotinib in Advanced NSCLC

Journal of Thoracic Oncology

English

Age Dependent Prognosis in Concurrent Chemo-Radiation of Locally Advanced NSCLC

English

MA05.10 the Pathologic Response of Locally Advanced NSCLC Treated With Concomitant Chemoradiation to 60 Gy in Image Guided Radiation Therapy (IGRT)

Journal of Thoracic Oncology

English

Leukocytosis and Neutrophilia Predict Outcome in Locally Advanced Esophageal Cancer Treated With Definitive Chemoradiation

Oncotarget

Oncology

2017

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Machtay

MA05.09 PFS and Cardiac-Toxicity-Adjusted-PFS as Predictors of OS in Locally Advanced NSCLC Treated With Concurrent Chemoradiation

The Clinical Value of FDG-PET/MRI in Treatment Planning and as a Predictor of Disease Response in High–Dose Rate Interstitial Brachytherapy for Locally Advanced Gynecologic Malignancies

Related publications

PC05.01 Debate 1: Which Is Most Important Efficacy Endpoint in First Line Trials in Advanced NSCLC PFS or OS - Point of View: PFS

Quality of Survivorship Among Patients With Locally Advanced NSCLC Treated With Chemoradiation on RTOG 0617

OA07.07 PFS and OS Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450)

(P080) Immune Parameters as Predictors of Pneumonitis and Survival in Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation

P2.17-25 Post-Treatment Neutrophil to Lymphocyte Ratio in Locally Advanced NSCLC Patients Treated With Concurrent Chemoradiotherapy

P3.01-084 Analysis on ALTER0303 Trial: ACECs Level May Correlate With Metastases Burden and Predict PFS of Anlotinib in Advanced NSCLC

Age Dependent Prognosis in Concurrent Chemo-Radiation of Locally Advanced NSCLC

MA05.10 the Pathologic Response of Locally Advanced NSCLC Treated With Concomitant Chemoradiation to 60 Gy in Image Guided Radiation Therapy (IGRT)

Leukocytosis and Neutrophilia Predict Outcome in Locally Advanced Esophageal Cancer Treated With Definitive Chemoradiation